Phase
Condition
Dementia
Memory Loss
Mild Cognitive Impairment
Treatment
N/AClinical Study ID
Ages 18-35 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subjects participants from the 2003 cohort
Exclusion
Exclusion Criteria:
Neuromuscular disease
Pathological central apnoea
Severe chronic lung disease with documented hypoxaemia or awake oxygen saturation <92%
Chronic respiratory failure (unrelated to OSA)
Acquired upper airway disease/obstruction
Craniofacial abnormalities (e.g. secondary to trauma and malignancy)
Other arrangement:
Subjects who have any respiratory illness within 2 weeks of the scheduled follow-upvisit will have their assessment re-arranged until they have fully recovered.
Subjects taking medications that may affect sleep, upper airway patency or bloodpressure (for example sedatives, stimulants, antihistamines, and cough medicine)within a week from recruitment will also be rescheduled to participate when they arefree from medication use for at least 2 weeks.
Subjects with hypertension and are on anti-hypertensive therapy are allowed tocontinue on their medication and the information will be obtained and recordedduring data collection.
Study Design
Study Description
Connect with a study center
Prince of Wales Hospital
Hong Kong, 999077
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.